102 related articles for article (PubMed ID: 18977340)
1. Spurious hyperbilirubinemia caused by naproxen.
Al Riyami N; Zimmerman AC; Rosenberg FM; Holmes DT
Clin Biochem; 2009 Jan; 42(1-2):129-31. PubMed ID: 18977340
[TBL] [Abstract][Full Text] [Related]
2. Naproxen metabolites interfere with certain bilirubin assays: elimination of interference by using a Roche bilirubin assay on the Hitachi 917 analyzer.
Dasgupta A; Langman LJ; Johnson M; Chow L
Am J Clin Pathol; 2010 Jun; 133(6):878-83. PubMed ID: 20472845
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing naproxen metabolite interference in total bilirubin assays.
Saifee NH; Ranjitkar P; Greene DN
Clin Biochem; 2016 Apr; 49(6):514-517. PubMed ID: 26589001
[TBL] [Abstract][Full Text] [Related]
4. Bilirubin Elevation Caused by Naproxen Overdose: A Case Report Highlighting Laboratory Interference.
Heutlinger O; Mathew T; Fujimoto D; Bharani V; Yamarik R; Baz S
Am J Case Rep; 2023 Oct; 24():e941267. PubMed ID: 37845784
[TBL] [Abstract][Full Text] [Related]
5. Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
J Chromatogr; 1992 Jul; 578(2):239-49. PubMed ID: 1400803
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.
Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP; Vree ML; Guelen PJ
Br J Clin Pharmacol; 1993 May; 35(5):467-72. PubMed ID: 8512758
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; Vree JB; Guelen PJ
Biopharm Drug Dispos; 1993 Aug; 14(6):491-502. PubMed ID: 8218967
[TBL] [Abstract][Full Text] [Related]
8. Estimation of total and direct serum bilirubin using modified micro assay method.
Aman A; Ul Qader SA; Bano S
Ital J Biochem; 2007 Jun; 56(2):171-5. PubMed ID: 17722660
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica.
Andersen JV; Hansen SH
J Chromatogr; 1992 Jun; 577(2):325-33. PubMed ID: 1400763
[TBL] [Abstract][Full Text] [Related]
10. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
[TBL] [Abstract][Full Text] [Related]
11.
Oliveira GM; DionÃsio TJ; Siqueira-Sandrin VS; Ferrari LAL; Bolani B; Parisi VA; Polanco NLDH; Colombini-Ishikiriama BL; Faria FAC; Santos CF; Calvo AM
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422246
[TBL] [Abstract][Full Text] [Related]
12. Manual micromethods for bilirubin determination in sera of adults and children and investigation of reasons for observed differences.
Blumenfeld TA; Steinbrink CF; Cheskin HS; George JD; Vogl TP
Am J Clin Pathol; 1978 Apr; 69(4):388-97. PubMed ID: 645637
[TBL] [Abstract][Full Text] [Related]
13. A modified Malloy-Evelyn procedure for total bilirubin in microsamples.
Shihabi ZK; Scaro J
Am J Med Technol; 1977 Oct; 43(10):1004-7. PubMed ID: 920747
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of the difference between transcutaneous bilirubinometry and total serum bilirubin for the classification of newborns at risk of hyperbilirubinemia.
RodrÃguez-Capote K; Kim K; Paes B; Turner D; Grey V
Clin Biochem; 2009 Feb; 42(3):176-9. PubMed ID: 18929552
[TBL] [Abstract][Full Text] [Related]
15. Interference by naproxen in the urinary 5-hydroxyindoleacetic acid assay is due to a metabolite, desmethylnaproxen.
Walker PL; Pettit BR; Sandler M
Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():177-81. PubMed ID: 2438972
[TBL] [Abstract][Full Text] [Related]
16. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia.
Maisels MJ; Deridder JM; Kring EA; Balasubramaniam M
J Perinatol; 2009 Sep; 29(9):612-7. PubMed ID: 19421200
[TBL] [Abstract][Full Text] [Related]
17. [Fluorometric method for the determination of naproxen and demethylnaproxen in serum and urine (author's transl)].
Held H
J Clin Chem Clin Biochem; 1978 Oct; 16(10):579-83. PubMed ID: 712339
[TBL] [Abstract][Full Text] [Related]
18. Isolation and identification of 6-desmethylnaproxen sulfate as a new metabolite of naproxen in human plasma.
Kiang CH; Lee C; Kushinsky S
Drug Metab Dispos; 1989; 17(1):43-8. PubMed ID: 2566468
[TBL] [Abstract][Full Text] [Related]
19. Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project.
Kuzniewicz M; Newman TB
Pediatrics; 2009 Mar; 123(3):1045-50. PubMed ID: 19255038
[TBL] [Abstract][Full Text] [Related]
20. [On a method of bilirubin determination (according to Jendrassik, Cleghorn and Grof)].
Morozova VT
Lab Delo; 1965; 10():588-91. PubMed ID: 4163293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
